T2D Clinical Trials in Changchun, Jilin
3 recruitingChangchun, Jilin, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus
MASH - Metabolic Dysfunction-Associated SteatohepatitisT2DM (Type 2 Diabetes Mellitus)
Shanghai Jiao Tong University School of Medicine300 enrolled17 locationsNCT07303803
Recruiting
Not Applicable
Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial
Artificial Intelligence (AI)Diabetes Mellitus Type 2 (T2DM)
The First Hospital of Jilin University400 enrolled1 locationNCT06957093
Recruiting
Not Applicable
Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients
T2DMT2DM (Type 2 Diabetes Mellitus)Type 2 Diabetic Patients
Beijing Hospital115 enrolled16 locationsNCT03987308